Related Experiment Video
Updated: Feb 27, 2026
09:29
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
31.0K
Therapeutics Against Filovirus Infection
John Connor1, Gary Kobinger2, Gene Olinger3
1Department of Microbiology, National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, 620 Albany Street, Boston, MA, 02118, USA. jhconnor@bu.edu.
Current Topics in Microbiology and Immunology
|June 28, 2017
Summary
Developing effective filovirus infection therapies requires balancing urgent treatment needs with rigorous safety testing. Research into antivirals, host-factor support, and passive immunity aims to identify new interventions beyond supportive care.
Area of Science:
- Virology
- Infectious Diseases
- Medical Countermeasures
Background:
- Filovirus infections pose significant public health threats requiring urgent therapeutic development.
- Current management relies heavily on supportive care, highlighting the need for advanced medical interventions.
- Existing research explores direct antivirals, host-factor modulation, and passive immunity as potential filovirus treatments.
Purpose of the Study:
- To review the current landscape of filovirus infection therapies.
- To address the challenges in developing and testing new treatments during outbreaks.
- To emphasize the importance of basic research in identifying novel therapeutic targets.
Main Methods:
- Review of existing scientific literature on filovirus research and therapeutic strategies.
- Analysis of the challenges in clinical trial design for outbreak scenarios.
- Synthesis of information on direct antivirals, host-factor supportive approaches, and passive immunity.
Main Results:
- Multiple therapeutic avenues, including antivirals and immunotherapies, are under investigation for filovirus infections.
- Balancing rapid treatment deployment with stringent safety and efficacy standards is a critical challenge.
- Understanding filovirus-host interactions is key to discovering effective interventions.
Conclusions:
- Effective management of filovirus outbreaks necessitates medical interventions beyond supportive care.
- Future therapeutic strategies will emerge from continued basic research into filoviruses and host responses.
- Careful clinical trial design is essential to balance patient benefit and scientific advancement.
More Related Videos
Related Concept Videos
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.6K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.6K
01:29Venous Thrombosis III: Interprofessional Care
423
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
423
01:26Pharmaceutical Poisoning: Treatment Strategies
77
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
77
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
01:29Subviral Agents
668
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
668
01:29Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K